ClinicalTrials.gg
CompletedNCT03322397Updated Feb 21, 2019

Adolescent Acts of Kindness Intervention

An interventional study of Self-Focused Acts of Kindness Intervention and Other-Focused Acts of Kindness Intervention in Inflammation and Mental Health Wellness 1, sponsored by University of California, Los Angeles. Completed at 1 site in United States. Open to participants aged 14 Years to 17 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-02-21.

Sponsored by University of California, Los Angeles · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
97
Allocation
Randomized
Ages
14 Years to 17 Years
Sex
All
01

Study summary

Adolescents will complete a 4-week intervention, during which they will either complete a kind act for others, complete a kind act for themselves, or report their daily activities three days per week. Psychological and physiological measures will be indexed before and after the intervention.

Read the detailed description

Stress and early adversity have been found to influence immune function via enhanced expression of the conserved transcriptional response to adversity (CTRA) genetic profile. Expression of this genetic profile was reduced in adults who completed a prosocial behavior intervention. This project aims to implement this intervention in adolescents. 90 high school students will be recruited and assigned to one of three groups (30/group). Participants will either conduct 3 acts of kindness for themselves, conduct 3 acts of kindness for others, or report about their day 3 times per week for 4 weeks. During this intervention, they will receive text messages 3 days per week instructing them to complete their respective act. Participants will provide a brief description of this act that evening, as well as complete brief surveys at the end of the week for each week of the intervention. Participants will come into the lab twice, once before and once after the 4-week intervention. During these lab sessions participants will complete survey measures, have their heart rate measured, and have a blood draw conducted by a trained phlebotomist. Participants' parents will also complete a brief survey to provide demographic information and an idea of what prosocial behaviors participants witnessed in their home. The investigators will use these data to assess the effects of prosocial behavior on health and the psychological mechanisms underlying these effects. At the second study visit, participants will be given the opportunity to donate part of their study payment to a charity to measure prosociality. Any donations will be vetted with the psychology department's accounting group prior to making any donations in the university's name. Scott Monatlik, Director, Tax and Information Practices, at smonatlik@finance.ucla.edu or (310) 794-6724 will be contacted and information regarding the appropriate steps to take to ensure that the donation is made to an acceptable charity prior to any donations. Actual helping behavior (donations) is measured to provide an ecologically valid experimental evaluation of prosociality rather than traditional metrics of computerized, fictional giving. Conceptual frameworks from developmental and health psychology guide the hypothesis that prosocial behavior will influence adolescents.

02

Conditions studied

  • Inflammation
  • Mental Health Wellness 1

Keywords

  • adolescence
  • immune function
  • gene expression
  • psychological well-being
  • social connection
  • kindness
03

In context

Inflammation

3,536 studies on the registry are indexed under Inflammation; 642 are open to participants now.

This study's enrollment of 97 is above the median of 50 across 2,577 interventional studies indexed under Inflammation.

Browse Inflammation studies →

Lead sponsor

University of California, Los Angeles is the lead sponsor of 1,170 studies on the registry; 195 are open to participants now.

Of its 95 completed or terminated interventional studies of FDA-regulated products, 70 (74%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
14 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Between the ages of 14-17

Exclusion criteria

Exclusion Criteria:

  • None
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
97 participants (actual)

Study arms

  • Experimental
    Kindness to Others

    Participants will complete the 'Other-Focused Acts of Kindness Intervention' by performing acts of kindness for others. They be asked to complete 3 kind acts for others throughout the week for 4 weeks. They will receive text messages three days per week (either Tuesday, Thursday, and Saturday or Wednesday, Friday, and Sunday) and will report on their kind act later that day.

    Behavioral: Other-Focused Acts of Kindness Intervention

  • Active comparator
    Kindness to Self

    Participants will complete the 'Self-Focused Acts of Kindness Intervention' by performing acts of kindness for themselves. They be asked to complete 3 kind acts for others throughout the week for 4 weeks. They will receive text messages three days per week (either Tuesday, Thursday, and Saturday or Wednesday, Friday, and Sunday) and will report on their kind act later that day.

    Behavioral: Self-Focused Acts of Kindness Intervention

  • Sham comparator
    Daily Report

    Participants will complete the 'Daily Reports' and be asked to report their daily activities throughout the week for 4 weeks. They will receive text messages three days per week (either Tuesday, Thursday, and Saturday or Wednesday, Friday, and Sunday) and will list activities from their day.

    Behavioral: Daily Reports

Interventions

  • BehavioralSelf-Focused Acts of Kindness Intervention

    Participants engage in positive behaviors by completing acts of kindness for themselves three times per week. These acts should require effort and be outside of an individual's normal routine.

  • BehavioralOther-Focused Acts of Kindness Intervention

    Participants engage in positive behaviors by completing acts of kindness for others three times per week. These acts should require effort and be outside of an individual's normal routine.

  • BehavioralDaily Reports

    Participants will report their daily activities three times per week. Aside from reporting at the end of the day, no changes should be made to the individual's normal routine.

06

What researchers measure

Primary outcomes

  1. Average Positive Affect

    Average Positive Affect as assessed by the positive affect subscale of the Affect Adjective Checklist. An average is taken across four items, and scores range from 1 to 5 with higher scores indicating more positive affect over the week.

    Time frame: Weekly over 5 weeks

Secondary outcomes

  1. Inflammatory Gene Expression

    Change in inflammatory gene expression from baseline to one week following the intervention as assessed by assays of the conserved transcriptional response to adversity profile of gene expression in leukocytes.

    Time frame: Baseline and one-week post intervention (elapsed time of 5 weeks)

  2. Average Psychological Flourishing

    Change in average psychological flourishing from baseline to one week following the intervention as assessed by Mental Health Continuum-Short Form at week 5. An average is taken across 20 items, and scores range from 1 to 6, with higher values representing greater psychological flourishing.

    Time frame: Baseline and one-week post intervention (elapsed time of 5 weeks)

  3. Average Negative Affect

    Average negative affect as assessed by the negative affect subscale of the Affect Adjective Checklist. An average is taken across five items, and scores range from 1 to 5 with higher scores indicating more negative affect over the week.

    Time frame: Weekly over 5 weeks

Other outcomes

  1. Average Stress

    Average stress as assessed by the Perceived Stress Scale. An average is taken across 10 items, and scores range from 1 to 5 with higher scores indicating greater stress.

    Time frame: Weekly over 5 weeks

  2. Sleep Quality

    Sleep quality as assessed by the Pittsburgh Sleep Quality Index (PSQI). The assessment has 7 components, each scored from 0 to 3. A sum is taken across these components, such that total scores range from 0 to 21 with higher scores indicating poorer sleep.

    Time frame: Weekly over 5 weeks

  3. Inflammatory Composite

    Change in inflammation from baseline to one week following the intervention as assessed by the concentration of a variety of inflammatory cytokines (e.g., IL-6, IL-1).

    Time frame: Baseline and one-week post intervention (elapsed time of 5 weeks)

  4. Respiratory Sinus Arrythmia (RSA)

    Change in RSA from baseline to one week following the intervention as assessed by high-frequency heart rate variability during paced breathing.

    Time frame: Baseline and one-week post intervention (elapsed time of 5 weeks)

  5. Average Social connection

    Average social connection as assessed by the relatedness subscale of the Balanced Measure of Psychological Needs. An average is taken across 6 items, and scores range from 1 to 5 with higher scores indicating greater social connection.

    Time frame: Weekly over 5 weeks

  6. Donation

    Donation as assessed by the amount of money participants donated (maximum of $10) to a charity for foster youth.

    Time frame: 5 weeks

07

Study locations

1 site
  • Adolescent Development Lab at UCLA
    Los Angeles, California 90066, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 21, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03322397
Responsible party
Andrew J. Fuligni, PhD (Principal Investigator, University of California, Los Angeles) — Principal investigator
First posted
Oct 26, 2017
Start date
Oct 8, 2017
Primary completion
Jan 13, 2019
Completion
Jan 13, 2019
Last update
Feb 21, 2019

Study contacts

Andrew Fuligni, PhD
principal investigator · Professor

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion